Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 62 Carcinoma, Hepatocellular 25 Neoplasm Metastasis 15 Rectal Neoplasms 11 Colonic Neoplasms 10 Gastrointestinal Stromal Tumors 9 Sarcoma 6 Ovarian Neoplasms 5 Osteosarcoma 5 Glioblastoma 5 Cholangiocarcinoma 5 Stomach Neoplasms 4 Melanoma 4 Liver Neoplasms 4 Sarcoma, Ewing 3 Pancreatic Neoplasms 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Esophageal Neoplasms 3 Colorectal Cancer Metastatic 3 Carcinoma, Non-Small-Cell Lung 3 Thyroid Neoplasms 2 Rhabdomyosarcoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Hematologic Neoplasms 2 Hemangiosarcoma 2 Gastrointestinal Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 12 gallium Ga 68 dotatate 6 Everolimus 6 lutetium Lu 177 dotatate 5 Radiosurgery 5 Proton Therapy 5 Bevacizumab 5 pembrolizumab 4 Surveys and Questionnaires 4 Specimen Handling 4 Hydroxyurea 4 abemaciclib 3 Tranexamic Acid 3 Surgical Procedures, Operative 3 Sodium Chloride 3 Ga(III)-DOTATOC 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 vistusertib 2 trametinib 2 ribociclib 2 arginyllysine 2 aldesleukin 2 Yoga 2 Whole Body Imaging 2 Sunitinib 2 Saline Solution 2 Ropivacaine 2 Radiotherapy 2 Protons 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Meningioma × regorafenib × Clear all

NCT06275919 2026-05-13

MIRAGE

Istituto Oncologico Veneto IRCCS

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡